#obesitytreatment — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #obesitytreatment, aggregated by home.social.
-
https://www.europesays.com/dk/83955/ Is Kailera Therapeutics a Buy After Its Sizzling IPO? #BiotechSector #IPO #NovoNordisk #ObesityTreatment #Therapeutics #WeightLossDrug
-
https://www.europesays.com/dk/81761/ Novo Nordisk Highlights New Wegovy Pill Data #NovoNordisk #ObesityTreatment #participants #WegovyPill #WeightLoss
-
https://www.europesays.com/dk/?p=74979 Novo Nordisk’s Weight-Loss Pill Fuels Fierce Rivalry with Eli Lilly #EliLilly #MarketShare #NovoNordisk #ObesityDrugs #ObesityTreatment #PharmaceuticalCompetition #PrescriptionGrowth #PricePressures #Wegovy #WeightLossPill
-
Rhythm gets EU approval for IMCIVREE in rare obesity
Rhythm Pharmaceuticals (NASDAQ: RYTM) announced the European Commission authorized IMCIVREE (setmelanotide) for treatment of obesity and control of…
#Europe #EU #acquiredhypothalamicobesity #EuropeanCommissionauthorization #EuropeanUnion #IMCIVREE #obesitytreatment #Phase3TRANSCEND #raredisease #RhythmPharmaceuticals #RYTM
https://www.europesays.com/europe/28270/ -
Obese Seek Weight Loss Drugs Amidst Shifting Insurance Tides
Insurance like Medicare and Medicaid are limiting coverage for weight loss drugs (Wegovy, Ozempic). Many obese patients now face higher costs or denied access.
#WeightLossDrugs, #Ozempic, #Wegovy, #InsuranceCoverage, #ObesityTreatment
https://newsletter.tf/weight-loss-drug-coverage-changes-obese-2026/
-
Insurance coverage for popular weight loss drugs like Wegovy and Ozempic is becoming harder to get. This is different from last year when more people could access them for obesity.
#WeightLossDrugs, #Ozempic, #Wegovy, #InsuranceCoverage, #ObesityTreatment
https://newsletter.tf/weight-loss-drug-coverage-changes-obese-2026/ -
https://www.europesays.com/ie/441115/ Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle #Éire #Genetics #GLP1ReceptorAgonists #Health #IE #Ireland #Medication #ObesityTreatment #OzempicDrug #PersonalisedObesityCare #semaglutide #SemaglutideBenefits #SemaglutideDrugs #SemaglutideForDiabetes #SemaglutideForWeightLoss #SemaglutideInjection #tirzepatide #Type2DiabetesDrug #Type2DiabetesDrugs #WeightLossWithSemaglutide #WeightLossDrugs
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
Weight loss and…
#NewsBeep #News #Medication #CA #Canada #Genetics #GLP1receptoragonists #Health #obesitytreatment #Ozempicdrug #personalisedobesitycare #Semaglutide #Semaglutidebenefits #semaglutidedrugs #Semaglutidefordiabetes #Semaglutideforweightloss #semaglutideinjection #tirzepatide #type2diabetesdrug #type2diabetesdrugs #weightlosswithsemaglutide #weight-lossdrugs
https://www.newsbeep.com/ca/611456/ -
https://www.europesays.com/ie/427390/ Probiotics may boost effectiveness of GLP-1 drugs in obesity treatment, study finds #Éire #GLP1Drugs #Health #IE #Ireland #ObesityTreatment #Probiotics #WeightLoss
-
https://www.europesays.com/dk/54196/ Emcure halves price of its semaglutide weight loss drug Poviztra after Novo Nordisk patent expiry — check new rates #NovoNordisk #ObesityTreatment #Poviztra #PriceReduction #SemaglutideInjection #WeightLossDrug #WeightManagementDrug
-
https://www.europesays.com/dk/?p=53659 Battle of the Giants: Lilly’s New Weight-Loss Pill vs. Novo Nordisk #EliLilly #FDAApproval #Foundayo #GLP1 #NovoNordisk #ObesityTreatment #orforglipron #PharmaceuticalCompetition #ThyroidTumors #WeightLoss
-
https://www.europesays.com/ie/409566/ Split Protein Builds the Infrastructure for Weight Loss #BrownFat #Éire #Genetis #Health #IE #Ireland #MetabolicHealth #Neuroscience #NYU #Obesity #ObesityTreatment #PLXNA1Receptor #SLIT3Protein #thermogenesis
-
Large Veterans Study Shows How GLP-1 Weight Loss Drugs Could Treat Addiction
Credit: MotivateBootCamp. Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact…
#NewsBeep #News #Health #Addictionresearch #alcoholusedisorder #brainrewardsystem #CA #Canada #diabetesdrugs #dopamine #glp-1drugs #metabolichealth #Neuroscience #obesitytreatment #opioidaddiction #Semaglutide #substanceusedisorder #VAstudy
https://www.newsbeep.com/ca/527512/ -
Daewoong Pharmaceutical has signed a global licensing deal for microneedle-based obesity patches, aiming to capture a share of the rapidly expanding $200 billion global obesity treatment market by 2030.
#YonhapInfomax #DaewoongPharmaceutical #ObesityTreatment #MicroneedlePatch #Semaglutide #GlobalMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106743 -
https://www.europesays.com/ie/273350/ People on fat loss jabs ‘put weight back on faster than traditional dieters’ – The Irish News #Éire #Health #IE #Ireland #Mounjaro #NHS #ObesityTreatment #SusanJebb #UK #UNIVERSITYCOLLEGELONDON #UniversityOfCambridge #UniversityOfOxford #UniversityOfSurrey #Wegovy #WeightLossMedication
-
Obesity Treatment Through Naturopathy in Raipur, Chhattisgarh | Five Lotus Indo German
https://fivelotusindogerman.com/obesity-treatment/
#ObesityTreatment #NaturopathyCare #NaturalWeightLoss #HolisticHealing #RaipurWellness #WeightLossJourney #FiveLotusIndoGerman #HealthyLiving #NaturopathyIndia
-
Scientists find brain cells that cause weight loss—without nausea. This could lead to safer, smarter obesity drugs. #BrainScience #ObesityTreatment #Semaglutide
https://geekoo.news/the-brain-cells-that-control-weight-loss-without-side-effects/
-
Novo Nordisk's ADR rises 1.04% to $80.98 following UBS's positive assessment and buy recommendation, despite overall market decline, as competition in obesity treatment market intensifies.
#YonhapInfomax #NovoNordisk #ADR #UBS #ObesityTreatment #GLP1 #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=54698 -
Novo Nordisk's disappointing clinical trial results for advanced obesity treatment lead to sharp declines in Wegovy-related stocks, impacting both Novo Nordisk and competitor Eli Lilly
#YonhapInfomax #NovoNordisk #ClinicalTrial #Wegovy #ObesityTreatment #EliLilly #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=53688 -
Eli Lilly announces $27 billion investment in US manufacturing to meet rising demand for obesity and diabetes treatments, creating 10,000 jobs amid tariff concerns
#YonhapInfomax #EliLilly #ManufacturingInvestment #ObesityTreatment #DiabetesTreatment #USJobCreation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=52300 -
🌍💊 Novo Nordisk's weight-loss drug Wegovy sees a massive 57% sales increase, doubling patient numbers to 2.2 million worldwide! The company anticipates up to 24% growth in 2025.
https://www.pharmacy.biz/news/novo-nordisk-sees-strong-surge-in-wegovy-sales/More details here: pharmacy.biz 🏥 #Healthcare #ObesityTreatment #NovoNordisk
-
Unlocking the power of bariatric surgery in the fight against obesity
Maria Iliakova is a bariatric and general surgeon.
https://youtube.com/shorts/V78qfm1rAJo
Listen here: https://kevinmd.com/podcast
#BariatricSurgery #ObesityTreatment #HealthcareApproach #CompassionateCare #MentalWellBeing #HolisticHealth #NoBlame #MedicalOptions #SurgicalInterventions
-
The Dark Side of Weight Loss: GLP-1 RAs Linked to Increased Psychiatric Risks
A groundbreaking study reveals a startling correlation between glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and heightened risks of depression, anxiety, and suicidal behavior in pat...
-
Effective obesity solutions beyond the norm: Genetics matter
Franchell Hamilton is a bariatric surgeon.
https://youtube.com/shorts/t1tdFeCNhxM
Listen here: https://kevinmd.com/podcast
#Healthcare #ObesityTreatment #GeneticFactors #PatientSupport #MedicalApproach #WeightStigma #AlternativeStrategies #HolisticHealth #GeneticInsights #PatientWellness
-
The Dark Side of Weight Loss: GLP-1 RAs Linked to Increased Psychiatric Risks
A groundbreaking study reveals a startling correlation between glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and heightened risks of depression, anxiety, and suicidal behavior in pat...
-
The Dark Side of Weight Loss: GLP-1 RAs Linked to Increased Psychiatric Risks
A groundbreaking study reveals a startling correlation between glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and heightened risks of depression, anxiety, and suicidal behavior in pat...
-
The Dark Side of Weight Loss: GLP-1 RAs Linked to Increased Psychiatric Risks
A groundbreaking study reveals a startling correlation between glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and heightened risks of depression, anxiety, and suicidal behavior in pat...
-
The Dark Side of Weight Loss: GLP-1 RAs Linked to Increased Psychiatric Risks
A groundbreaking study reveals a startling correlation between glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and heightened risks of depression, anxiety, and suicidal behavior in pat...
-
Unlocking the power of bariatric surgery in the fight against obesity
Maria Iliakova is a bariatric and general surgeon.
https://youtube.com/shorts/V78qfm1rAJo
Listen here: https://kevinmd.com/podcast
#BariatricSurgery #ObesityTreatment #HealthcareApproach #CompassionateCare #MentalWellBeing #HolisticHealth #NoBlame #MedicalOptions #SurgicalInterventions
-
Unlocking the power of bariatric surgery in the fight against obesity
Maria Iliakova is a bariatric and general surgeon.
https://youtube.com/shorts/V78qfm1rAJo
Listen here: https://kevinmd.com/podcast
#BariatricSurgery #ObesityTreatment #HealthcareApproach #CompassionateCare #MentalWellBeing #HolisticHealth #NoBlame #MedicalOptions #SurgicalInterventions